Combo Therapy with Growth Hormone Could Improve Bone Development in XLH, Mouse Study Suggests
If combined with an approach that targets hallmark abnormalities in X-linked hypophosphatemia (XLH), treatment with growth hormone could normalize bone growth and structure in these patients, a study in mice suggests. The study, “MAPK inhibition and growth hormone: a promising therapy in XLH,” was published…